logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Sikdar, Soumick, Dr
    Born in February 1982
    Individual (11 offsprings)
    Officer
    2019-05-21 ~ now
    OF - Director → CIF 0
    Dr Soumick Sikdar
    Born in February 1982
    Individual (11 offsprings)
    Person with significant control
    2019-05-21 ~ 2021-11-30
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    2021-11-30 ~ 2024-02-21
    PE - Right to appoint or remove directorsCIF 0
  • 2
    SIKDAR CONSULTING LTD
    - now 08277789 09451022
    S SIKDAR UK LTD - 2018-03-02
    3, Campbell Court, Bramley, Tadley, England
    Active Corporate (1 parent, 2 offsprings)
    Person with significant control
    2024-02-21 ~ now
    PE - Right to appoint or remove directors with control over the trustees of a trustCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directors as a member of a firmCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

CLYDESDALE PHARMA LTD

Period: 2019-12-23 ~ now
Company number: 12009053
Registered names
CLYDESDALE PHARMA LTD - now
SIKDAR PHARMA LTD - 2019-12-23
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
1,906,284 GBP2025-03-31
1,192,679 GBP2024-03-31
Property, Plant & Equipment
26,099 GBP2025-03-31
25,926 GBP2024-03-31
Fixed Assets
1,932,383 GBP2025-03-31
1,218,605 GBP2024-03-31
Total Inventories
1,008,172 GBP2025-03-31
499,221 GBP2024-03-31
Debtors
531,296 GBP2025-03-31
547,522 GBP2024-03-31
Cash at bank and in hand
3,235 GBP2025-03-31
1,601 GBP2024-03-31
Current Assets
1,542,703 GBP2025-03-31
1,048,344 GBP2024-03-31
Creditors
Amounts falling due within one year
-625,105 GBP2025-03-31
-586,809 GBP2024-03-31
Net Current Assets/Liabilities
917,598 GBP2025-03-31
461,535 GBP2024-03-31
Total Assets Less Current Liabilities
2,849,981 GBP2025-03-31
1,680,140 GBP2024-03-31
Creditors
Amounts falling due after one year
-1,213,550 GBP2025-03-31
-763,124 GBP2024-03-31
Net Assets/Liabilities
1,632,223 GBP2025-03-31
915,629 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Revaluation reserve
1,590,049 GBP2025-03-31
875,000 GBP2024-03-31
Retained earnings (accumulated losses)
42,074 GBP2025-03-31
40,529 GBP2024-03-31
Equity
1,632,223 GBP2025-03-31
915,629 GBP2024-03-31
Average Number of Employees
92024-04-01 ~ 2025-03-31
52023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
Other
1,906,284 GBP2025-03-31
1,192,679 GBP2024-03-31
Intangible Assets - Gross Cost
1,906,284 GBP2025-03-31
1,192,679 GBP2024-03-31
Intangible assets - Disposals
-1,444 GBP2024-04-01 ~ 2025-03-31
Intangible Assets
Other
1,906,284 GBP2025-03-31
1,192,679 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
8,575 GBP2025-03-31
5,550 GBP2024-03-31
Furniture and fittings
5,058 GBP2025-03-31
5,058 GBP2024-03-31
Computers
35,086 GBP2025-03-31
33,331 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
48,719 GBP2025-03-31
43,939 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,220 GBP2025-03-31
1,665 GBP2024-03-31
Furniture and fittings
2,353 GBP2025-03-31
1,847 GBP2024-03-31
Computers
18,047 GBP2025-03-31
14,502 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
22,620 GBP2025-03-31
18,014 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
555 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
506 GBP2024-04-01 ~ 2025-03-31
Computers
3,545 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
4,606 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
6,355 GBP2025-03-31
3,885 GBP2024-03-31
Furniture and fittings
2,705 GBP2025-03-31
3,211 GBP2024-03-31
Computers
17,039 GBP2025-03-31
18,830 GBP2024-03-31

  • CLYDESDALE PHARMA LTD
    Info
    SIKDAR PHARMA LTD - 2019-12-23
    Registered number 12009053
    Unit 3-5 Campbell Court, Bramley, Tadley RG26 5EG
    PRIVATE LIMITED COMPANY incorporated on 2019-05-21 (7 years). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-29
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.